Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS (2020)
- Authors:
- USP affiliated authors: MARTINS, MILTON DE ARRUDA - FM ; LEICK, EDNA APARECIDA - FM ; TIBÉRIO, IOLANDA DE FÁTIMA LOPES CALVO - FM
- Unidade: FM
- DOI: 10.3389/fphar.2020.01269
- Subjects: DOENÇAS VASCULARES; ASMA; LIPOPOLISSACARÍDEOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Frontiers in pharmacology
- ISSN: 1663-9812
- Volume/Número/Paginação/Ano: v. 11, article ID 1269, 18p, 2020
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
CAMARGO, Leandro do Nascimento et al. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS. Frontiers in pharmacology, v. 11, 2020Tradução . . Disponível em: https://doi.org/10.3389/fphar.2020.01269. Acesso em: 15 fev. 2026. -
APA
Camargo, L. do N., Santos, T. M. dos, Andrade, F. C. P. de, Fukuzaki, S., Lopes, F. D. T. Q. dos S., Martins, M. de A., et al. (2020). Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS. Frontiers in pharmacology, 11. doi:10.3389/fphar.2020.01269 -
NLM
Camargo L do N, Santos TM dos, Andrade FCP de, Fukuzaki S, Lopes FDTQ dos S, Martins M de A, Prado CM, Leick EA, Righetti RF, Tiberio I de FLC. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2026 fev. 15 ] Available from: https://doi.org/10.3389/fphar.2020.01269 -
Vancouver
Camargo L do N, Santos TM dos, Andrade FCP de, Fukuzaki S, Lopes FDTQ dos S, Martins M de A, Prado CM, Leick EA, Righetti RF, Tiberio I de FLC. Bronchial vascular remodeling is attenuated by anti-IL-17 in asthmatic responses exacerbated by LPS [Internet]. Frontiers in pharmacology. 2020 ; 11[citado 2026 fev. 15 ] Available from: https://doi.org/10.3389/fphar.2020.01269 - Effects of the serine protease inhibitor rBmTI-A in an experimental mouse model of chronic allergic pulmonary inflammation
- Protective effects of anti-IL17 on acute lung injury induced by LPS in mice
- Plant Proteinase Inhibitor BbCI Modulates Lung Inflammatory Responses and Mechanic and Remodeling Alterations Induced by Elastase in Mice
- The plant proteinase inhibitor crataBL plays a role in controlling asthma response in mice
- A Plant Proteinase Inhibitor from Enterolobium contortisiliquum Attenuates Pulmonary Mechanics, Inflammation and Remodeling Induced by Elastase in Mice
- Modulating asthma-COPD overlap responses with IL-17 inhibition
- Modulation of chronic airway inflammation by oral tolerance:: effects in lung mechanics, exhaled nitric oxide and airway hyperresponsiveness to methacholine in guinea pigs
- Effects of acute inhibition of nitric oxide synthase in the lung mechanics on a model of chronic airway inflammation in guinea pigs treated with capsaicin
- Exhaled nitric oxide in a model of chronic airway inflammation: modulation by montelukast sodium and dexamethasone treatment
- Capsaicin treatment in a model of chronic airway inflammation in guinea pigs: modulation by nitric oxide synthase inhibitor
Informações sobre o DOI: 10.3389/fphar.2020.01269 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
